NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Sound Bioventures

Sound Bioventures

Overview

Sound Bioventures is a venture capital fund investing in about-to-be clinical and clinical stage private companies in Europe and the USA developing novel medicines that addresses unmet medical needs. The fund focuses on companies with assets in clinical or about-to-be-clinical stage in primarily orphan and rare diseases. It leverages Scandinavian science to build companies and facilitate cross-Atlantic exchange of innovation, sector knowledge and capital.

Year Founded

2021

Portfolio Companies

11

Investments

Sound Bioventures investments
CompanyDateStageLead
Cytospire TherapeuticsMay 2026Series ACo-investor
BOOST PharmaNov 2025Convertible DebtLead
ARTHEx BiotechSep 2025Series BCo-investor
AnaCardioJan 2025Series A ExtensionLead
Artax BiopharmaAug 2024Convertible DebtCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSweden
Year Founded2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.